Connect with us

Technology

‘Control: Ultimate Edition’ headlines February’s batch of PS Plus freebies – Yahoo Finance Australia

The messy next-gen upgrade saga just took another twist.

Published

on

post featured image
ADVERTISEMENT

NEW YORK, Jan. 27, 2021 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that an analyst note commenting on the listing of Intercepts product on the U.S. Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) website reached a conclusion regarding the status of a newly identified safety signal (NISS)…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending